Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000902664-25-002479·Aura Biosciences, Inc.
Schedule 13D ownership disclosure
Aura Biosciences Inc
Common Stock, par value $0.00001 per share · CUSIP: 05153U107
Event date: 2025-05-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Matrix Capital Management Company LPReported CIK 0001410830
Shares: 6,922,870.00 · Class: 11.17%
- David E. GoelReported CIK 0001548144
Shares: 6,922,870.00 · Class: 11.17%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002479
- Form type
- SCHEDULE 13D/A
- Filer
- Aura Biosciences, Inc.
- CIK
- CIK 1501796
- Filed
- May 19, 2025
- Reporting period
- May 16, 2025
- Description
- Schedule 13D beneficial ownership